Home Blog Page 551

Maria Toler Velissaris Awarded 2022 Eisenhower Fellowship

0
Maria Toler Velissaris Awarded 2022 Eisenhower Fellowship
Maria Toler Velissaris, Founding Partner of SteelSky Ventures, was selected for the prestigious Eisenhower Fellowship where she will travel to Rwanda and Spain to progress the state of maternal healthcare

ATLANTA - September 7, 2022 - (Newswire.com)

Maria Toler Velissaris, Founding Partner of SteelSky Ventures, has been selected for the prestigious Eisenhower Fellowship through its 2022 USA Justice Fellows, an inaugural program that sends mid-career U.S. professionals abroad to expand their horizons and sharpen their strategies for combatting entrenched racial discrimination in their communities and professions.

Velissaris will travel to Rwanda and Spain this fall to meet with top healthcare and government leaders. In Rwanda, she will focus on technologies that advance the state of maternal health care and, in Spain, she will study the country's single-payer health insurance system.

"This fellowship presents a unique opportunity to explore new and innovative care delivery models in a global context," Velissaris said. "Health equity is foundational to our work at SteelSky Ventures, and I'm eager to return with fresh insights into expanding access and improving outcomes in women's health nationally and globally."

"These dynamic leaders join a global network of Fellows who for nearly seven decades have been striving to create a world more peaceful, prosperous and just," said Robert M. Gates, EF Chairman and former U.S. Secretary of Defense. "Their work advances the core justice pillar of our founding mission."

Enforcing racial equality through the rule of law, President Dwight D. Eisenhower sent troops from the U.S. Army's 101 Airborne Division to Little Rock, Arkansas, in 1957 to protect the Constitutional right of Black students to attend a segregated all-white high school. More than six decades later, amid a national reckoning of relations between the races, Eisenhower Fellowships is advancing the legacy of its namesake with its inaugural 2022 USA Justice Program.

"The Justice Program employs our historic foundation of direct dialogue to enhance understanding and shape solutions to the vexing inequalities that disproportionately affect African-Americans and other communities of color," said George de Lama, EF President.

Maria Toler Velissaris founded SteelSky Ventures in 2020 to improve access, care and outcomes in women's healthcare by finding investment opportunities in innovative medical devices, digital tools and delivery models. Today, her firm has $73 million in assets under management.

For the biographies of each of the USA Justice Program Fellows, please click here.

About SteelSky Ventures

SteelSky Ventures is a black female-led venture capital fund investing in companies that improve access, care, and outcomes in women's healthcare. With $73 million in assets under management, SteelSky Ventures is the largest venture capital fund focused on women's healthcare. For more information about SteelSky Ventures, visit https://steelskyventures.com

About Eisenhower Fellows

Now in its 69th year and named for America's 34th president, EF brings together innovative leaders from across geographies and sectors to tackle big challenges and improve the world. Since 1953, more than 2,400 mid-career leaders from 115 countries have benefited from the unique experience of an Eisenhower Fellowship.

PR Contact: [email protected]


Related Files
Screen Shot 2022-09-06 at 9.23.33 PM.png



Press Release Service by Newswire.com

Original Source: Maria Toler Velissaris Awarded 2022 Eisenhower Fellowship

Lake City, Co. Hosts the Uncorked Wine and Music Festival Sept. 17, 2022

0
Lake City, Co. Hosts the Uncorked Wine and Music Festival Sept. 17, 2022
There are so many things to do in Lake City, Co. See fall colors, explore the Alpine Loop, hike, fish, camp, relax and enjoy Lake City, Co.'s annual Uncorked Wine and Music Festival.

LAKE CITY, Colo. - September 7, 2022 - (Newswire.com)

With so many things to do in Lake City, Co. and so many ways to create lasting memories, no wonder Lake City, Co. is a popular repeat vacation destination. Lake City is a hub for enthusiasts of all kinds because one can hike, bike, fish, camp, RV, kayak, SUP and ATV from one central location. Lake City Loopers ATV Rentals supports the Lake City community including the Uncorked Wine and Music Festival.

On September 17, Lake City, Co. hosts the Uncorked Wine and Music Festival. The lineup includes seven musical acts, artisan food vendors, and various wines, it's a great way to meet people and relax in style. All proceeds from the festival support local community projects.

To enjoy the outdoors and experience the changing colors of fall, explore the Alpine Loop on an all-terrain vehicle from Lake City Loopers ATV Rentals. The Alpine Loop is a 75-mile+ trail system that traverses 13,000' passes and offers sights of waterfalls and well-preserved old-west mining towns, mills, and mines.

Lake City offers several restaurants, lodging, camping and entertainment options including the following:

  • In the morning, fuel up with breakfast at Chillin', a local favorite for their tasty breakfast burritos.
  • Spend a day on the loop with an ATV Rental from popular Lake City Loopers ATV Rentals, which offers reliable 5-seat Honda 1000s. 
  • In the evening, Lake City Brewing Company offers locally brewed beverages. Relax outside or belly up to the bar and enjoy a gourmet brat.
  • Check out Packer Saloon & Cannibal Grill. With their large patio and campfire-style outdoor fire-pit, this is a great place to relax.
  • And don't forget ice cream for dessert. The San Juan Soda, Co. is centrally located right across the city park on Silver Street.

Looking for a campsite, RV site or motel? Lake City, Co. has you covered.

Lake City, Co. is a fall travel destination because of its many activities and access to the Alpine Loop. For more information contact Steve Twyman of Lake City Loopers at 970-944-0553 or [email protected].




Press Release Service by Newswire.com

Original Source: Lake City, Co. Hosts the Uncorked Wine and Music Festival Sept. 17, 2022

New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine

0
New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine
WASHINGTON - September 7, 2022 - (Newswire.com)

A recently published article in Experimental Biology and Medicine (Volume 247, Issue 15, August, 2022) challenges that mouse embryonic stem cells are dependent on threonine. The study, led by Dr. Jian Feng in the Department of Physiology and Biophysics at the State University of New York, Buffalo, finds that mouse embryonic stem cells do not have a unique requirement for threonine.  

Threonine is an amino acid used in the biosynthesis of proteins. An influential study published in 2009 claims that the growth and proliferation of mouse embryonic stem cells (mESCs) have a unique dependence on threonine. The study has generated significant interest and many subsequent papers are published based on this claim. It has become accepted that mESCs have a special requirement for threonine to grow and multiply.

In this study, Drs. Feng and Boyang Zhang replicate the experiments in the previous study and use the serum-free, 2i/LIF medium to test if mESCs have a dependence on threonine. In the individual absence of methionine or valine, the growth and proliferation of mESCs in serum are as severely affected as in the absence of threonine. Removing even a non-essential amino acid such as arginine or glutamine significantly attenuates the growth and proliferation of mESCs. The present study thus set the record straight on the amino acid requirement of mESCs by finding that, just like most types of cells, mESCs do not have a special requirement for threonine. The study will move the field forward to a more comprehensive understanding of cellular metabolism in mESCs, which serve as the bedrock of stem cell biology because they can generate all types of cells in a mouse.

Drs. Feng and Zhang said: "We were very excited by the previous paper claiming the unique requirement of threonine in mESCs and wanted to understand why. To our surprise, our experiments show that there is nothing unique about threonine; mESCs cannot grow in the individual absence of many other amino acids. We thank Experimental Biology and Medicine for letting us set the record straight."

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said, "Zhang and Feng have tested the dogma that mesenchymal stem cells (mESCs) have a unique requirement for threonine when cultured in medium containing serum and leukemia inhibitory factor (LIF). Their study clearly demonstrates that the growth and proliferation of mESCs in serum/LIF or in a serum-free medium (2i/LIF) requires many essential and non-essential amino acids. This study provides clarity for those working in the stem cell field on the amino acid requirements of mESCs."

Experimental Biology and Medicine is a global journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903. Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership, visit www.sebm.org. If you are interested in publishing in the journal, please visit http://ebm.sagepub.com/.

For more information, please contact [email protected].




Press Release Service by Newswire.com

Original Source: New Study Finds Mouse Embryonic Stem Cells Have No Special Requirement for Threonine

How to Check if You Are Pre-Approved for a Personal Loan

0
How to Check if You Are Pre-Approved for a Personal Loan
NEW YORK - September 7, 2022 - (Newswire.com)

Credello: When you're looking for a personal loan, knowing if you're pre-approved for one can be helpful. Checking your pre-approval status can help you better understand the loan options available to you and also give you peace of mind in knowing that you're considered a safe investment by the lender. But if you're worried that you're not a good candidate, don't worry. Getting a pre-qualified personal loan can be a lot easier than you might think, and it can save you a lot of time and hassle. Here's what you need to know.

What are the benefits of being pre-approved for a personal loan?

Personal loans are a great way to get the money you need without having to dip into your savings or borrow from loved ones. That said, not everyone is a good candidate for a personal loan, so checking whether or not you're prequalified can prevent a hit to your credit report from the hard inquiry. 

In addition, being pre-approved means that you'll have a better understanding of the interest rates and terms you're eligible for. This can save you time and money in the long run, as you won't have to go through the hassle of applying for a personal loan only to be turned down because you didn't understand the terms or getting offers for terms that are well outside your budget.

How do I check my pre-approval status?

The best way to check your pre-approval status is to contact your potential lender directly. Many lenders offer online applications, but if you're not comfortable filling out an online application, you can also head directly to one of their branch locations (if they have brick-and-mortar offices).

You'll need to provide basic information, including your name, birth date, social security number, and income levels. The lender will then see what eligible terms you qualify for.

If you find out you've pre-qualified for a loan, great! You can now start to prepare yourself for the application process. But remember, pre-approval is not a guarantee of getting a loan. You still have to meet all of the lender's eligibility requirements, and sometimes banks and lenders can change their terms at any time.

If you're not pre-approved, there are still ways to get a personal loan. You can try another lender or search for a loan that better meets your needs. Many options are available, so don't feel limited by your pre-approval status. However, be sure to compare interest rates and terms carefully before applying, as some lenders offer lower rates if you're pre-approved.

So whether you're pre-approved or not, make sure you understand your options before making a decision. And if you have any questions about the pre-approval process, contact your potential lender for help.

Tips for ensuring you get pre-approved for a personal loan

There are a few things you can do to make sure you get pre-approved for a personal loan before you apply. First, make sure your financial history is in order. This includes ensuring your credit score is up-to-date and that there aren't any errors on your report. You'll also need copies of recent pay stubs and banking information.

Next, find a lender that is compatible with your financial situation and goals. You'll typically have better luck working with a lender with whom you have a prior relationship.

Finally, be prepared to provide documentation of your income and debts when you apply for a personal loan. The more proactive you are with providing information, the higher likelihood you'll get pre-approved.

The bottom line

Pre-approval is a critical step in the personal loan process. Make sure you take the time to investigate your options first before applying and be prepared to provide documentation that supports why you're qualified.




Press Release Service by Newswire.com

Original Source: How to Check if You Are Pre-Approved for a Personal Loan

Thistle Farms Welcomes Tasha Bandy Kennard as CEO and Scott Ryder as CFO

0
Thistle Farms Welcomes Tasha Bandy Kennard as CEO and Scott Ryder as CFO
Executive leadership appointments come as Thistle Farms crosses $12 million mark in annual donations and social enterprise revenue

NASHVILLE, Tenn. - September 7, 2022 - (Newswire.com)

Thistle Farms, a nonprofit social justice enterprise serving women survivors of trafficking, prostitution, and addiction, has announced the appointments of two executive leaders. 

Tasha Kennard has been named chief executive officer. With an extensive leadership history in non-profit, for-profit, and entrepreneurial sectors, Kennard brings a wealth of executive experience, financial oversight, and organizational development to the role. As CEO, she will partner with founder and President Becca Stevens, the board of directors, and the leadership team to fulfill the mission of Thistle Farms, support continued sustainable growth, and further evolve its long-term strategy while ensuring a collaborative, positive, trauma-informed, diverse, and inclusive environment. Kennard follows Hal Cato, who recently stepped down after a six-year period of enormous growth for Thistle Farms.

"Thistle Farms is a beacon of hope — an organization founded on healing and radical hospitality," says Kennard. "I feel a strong calling to this work as it weaves together my values, gifts, and experiences like a patchwork quilt — similar to the women entrepreneurs Thistle Farms supports in our community and across the globe. I'm grateful for the opportunity to support and expand our ability to serve, love, and champion women survivors by providing a safe place to live, a meaningful job, and lifelong sisterhood of support."

Scott Ryder has joined as Thistle Farms' first chief financial officer. The elevation in financial leadership was set in motion as the organization grew from $8.5 million to $12.6 million over the last 12 months. As CFO, Ryder will help steward the organization's investment in programs, sustainable growth, and overall impact. 

"Thistle Farms' mission is one that I believe in wholeheartedly," Ryder said. "As a mission interwoven with social enterprise, its model is uniquely structured to merge impact with economic opportunity for the women it serves. I am honored to help steward our finances as we step into the future." 

"I am filled with hope as I think about this new chapter for Thistle Farms. Both Tasha and Scott are uniquely qualified for leading Thistle Farms and are passionate about expanding our services for women survivors and increasing our presence nationally," said President Becca Stevens. "Our next chapter will be about creativity and scalable growth made possible by all the donors, volunteers, survivors, and allies that have nurtured us for 25 years."

Driven to serve the community, Kennard has led innovative solutions that simultaneously closed gaps for the underserved while lifting up entrepreneurs. As Executive Director of the Nashville Farmers' Market, Kennard led efforts to revitalize the 200-year-old beloved institution, including a $7 million renovation; establishment of small business incubation programs; and a statewide food-security program that doubled the buying power for EBT customers and secured $1 million in grant funding during the pandemic. Kennard has most recently served at Southall Farms, a farm resort and hospitality company, and has also served as Vice President of Marketing and Communications for Second Harvest Food Bank of Middle Tennessee. 

Ryder's 25+ years of executive and finance leadership experience will be invaluable on both the nonprofit and social enterprise sides of the organization. Most recently, Ryder served as CFO of Casa de Amparo, an organization addressing child abuse and neglect in San Diego County and beyond. Ryder earned an M.B.A. from the Paul Merage School of Business at U.C. Irvine, and a Bachelor of Arts degree in Economics from University of Redlands. 

"On behalf of the Board, I am excited to welcome Tasha and Scott to Thistle Farms," said Parag Desai, Thistle Farms Board of Directors President and Genesco's SVP, Chief Strategy and Digital Officer. "Both Tasha and Scott bring deep and relevant experience and a commitment to culture and community which is closely aligned with Thistle Farms' values and strategy. As leaders, Tasha and Scott embody the spirit that underpins our mission to help women survivors recover and heal from prostitution, trafficking, and addiction." 

The last three years have seen unprecedented growth for the organization. Fiscal support has poured in from customers, donors, wholesale accounts, corporate partnerships, and grants. The resulting cash flow has been reinvested into expansions on both the program and social enterprise sides of the organization — creating more opportunities for healing, housing, and employment for women survivors. 

ABOUT THISTLE FARMS 

Thistle Farms works with women survivors to overcome and heal from systems of prostitution and exploitation. The model provides housing, healing, and employment; a national network of more than 550 long-term free beds for women survivors; and a community of advocates who believe that love is the most powerful force for change in the world. For more information, visit thistlefarms.org

MEDIA CONTACT: 
Amanda Clelland
Thistle Farms Sr. Media Relations & Communications Manager 
[email protected] 
615.298.1140 x8




Press Release Service by Newswire.com

Original Source: Thistle Farms Welcomes Tasha Bandy Kennard as CEO and Scott Ryder as CFO

Iodine Software Teams With TruCode to Help Health Systems Capture More Earned Revenue

0
Iodine Software Teams With TruCode to Help Health Systems Capture More Earned  Revenue
Iodine Software's 2022 Best in KLAS solution integrates with TruCode Encoder Essentials software to drive more efficient and accurate clinical documentation improvement.

AUSTIN, Texas - September 7, 2022 - (Newswire.com)

Iodine Software, the leading enterprise AI software in healthcare, and TruCode, a CPSI company that provides encoder technology solutions that maximize coding efficiency, today announced a partnership that enables health systems and hospitals to more effectively perform clinical documentation improvement (CDI).

Iodine Software will integrate TruCode Encoder Essentials directly into its AwareCDI suite. The combined solutions will provide CDI teams with easy access to detailed diagnosis and procedure code reference information directly in their workflows, in addition to access to complete official code books.

"Clinical documentation improvement is one of the most important areas of hospital operations and has a direct impact on both revenue performance and clinical quality. However, it often requires healthcare professionals to complete complex and tedious work that can negatively impact organizational performance. We want our clients' CDI teams to have the best tools and resources available to them to streamline their work, minimize stress and create a positive working environment," said William Chan, Iodine Software Co-founder and CEO. "Providing TruCode's industry-leading technology within our AwareCDI Suite will allow CDI professionals to have the confidence that every claim has a complete and accurate reflection of the patient encounter, ultimately supporting earned-revenue opportunities and reducing denials."

AwareCDI is based on Iodine Software's proprietary CognitiveML technology, the most advanced and versatile AI engine available in healthcare. It's the only available market solution that addresses mid-cycle revenue cycle leakage at each step, which is one reason why it was recently named the 2022 Best In KLAS CDI Software by KLAS Research with a score of 91.2.

By embedding TruCode's robust coding resources directly into AwareCDI, CDI teams can easily access resources that support accurate capture of documentation and code assignment resulting in appropriate claim reimbursement and accurate reporting of patient outcomes.

"This partnership offers tremendous opportunity for hospitals and health systems because it brings together two industry-leading technologies, each with proven success. By combining TruCode's expertise in encoder technology and coding workflows with Iodine's powerful AI engine, we can deliver real value for healthcare organizations looking to improve the quality of care they deliver while improving revenue capture," said Chris Fowler, CPSI CEO.

An estimated 84 percent of healthcare leaders believe that a root cause of lost or decreased revenue is inaccurate clinical documentation and coding, which can cost the average hospital $5-10M for the average 250-bed hospital in revenue leakage. By integrating AI and coding software directly into a CDI team's workflow, provider organizations can capture earned revenue and minimize physician burnout caused by documentation and coding processes.

About Iodine Software
Iodine is an enterprise AI company that is championing a radical rethink of how to create value for healthcare professionals, leaders, and their organizations: automating complex clinical tasks, generating insights and empowering intelligent care. Iodine's powerful predictive engine complements the skills and judgment of healthcare professionals by interpreting raw clinical data to generate real-time, highly focused, predictive insights that clinicians and hospital administrators can leverage to dramatically augment the management of care delivery - facilitating critical decisions, scaling clinical workforces through automation, and improving the financial position of health systems. For more information, please visit iodinesoftware.com. 

About TruCode
TruCode offers innovative medical coding software solutions to the hospital, consulting, and healthcare IT markets. Since 2005, TruCode's team of passionate and experienced health information professionals has been dedicated to developing the most intuitive encoder available.
The release of the Encoder Essentials in 2011—a set of web services and components that allow TruCode's encoder technology to be embedded within other software platforms—took TruCode to new heights. Industry-leading Computer Assisted Coding (CAC), Clinical Documentation Improvement (CDI), and auditing solutions providers have partnered with TruCode to incorporate their encoder functionality into their own software.
In 2021, CPSI saw the value of bringing leading coding technology to their TruBridge business and acquired TruCode. As part of TruBridge, TruCode's solutions have helped to enhance TruBridge's patient management and revenue cycle solutions, helping them more effectively clear the way for care.

PR Contact: 
[email protected]




Press Release Service by Newswire.com

Original Source: Iodine Software Teams With TruCode to Help Health Systems Capture More Earned Revenue

Concordance Names Clinton ‘Lee’ Holmes as Chief Administrative Officer

0
Concordance Names Clinton ‘Lee’ Holmes as Chief Administrative Officer
ST. LOUIS - September 7, 2022 - (Newswire.com)

Concordance, a CARF accredited, non-profit re-entry program headquartered in St. Louis, announced today that Clinton "Lee" Holmes has joined Concordance as Chief Administrative Officer. He will report to Danny Ludeman, Concordance Chairman & CEO.

In his role at Concordance, Mr. Holmes will be responsible for executing administrative oversight for several departments across the organization including finance, human resources, information technology, and facilities. He will also oversee the implementation of organizational policies across administrative and participant service departments.

"Having worked as an employment partner with Concordance for two and a half years, I got to see first-hand how they impacted the lives of justice-involved individuals and personally experience the passion and caring their team members exhibited while interacting with Concordance participants," said Mr. Holmes. "This experience has impacted me significantly, to such a degree that I am proud to have joined this inspiring organization and work alongside the Concordance team members and participants that I have gotten to know!"

Mr. Holmes joins Concordance from Triad Manufacturing, having served as their Human Resources Manager. As Human Resources Manager, he led all aspects of human resources, including benefits, recruiting, training, strategy management, worker's compensation, 401K, and the Employee Stock Ownership Plan (ESOP). He also served on Concordance's Employer Advisory Council where he provided valuable insight on trends in the talent market and how they could impact the Concordance Employment Agency. Before joining Triad Manufacturing, Mr. Holmes was the Chief Operating Officer of NVision IT where he managed navigating business relationships within the government contracting sector.

"Through Concordance's partnership with Triad Manufacturing as a hiring partner and by serving on the Concordance Employer Advisory Council, Lee's passion for our mission and the well-being of our participants was obvious," said Ludeman. "As Chief Administrative Officer, Lee's role will be critical to our organization as we expand the Concordance Re-Entry Model nationally to 11 new cities in the next five years. And I am honored that he is joining us on this journey."

With over 20 years of experience in HR, Finance, and IT, Mr. Holmes has vast expertise in financial reporting, banking relations, corporate and legal oversight, risk mitigation, employee relations, safety management, recruiting, benefits, regulatory compliance, and business development. Mr. Holmes is a retired Major with the United States Army Reserve and earned his Bachelor of Arts in Business Administration, with an Accounting minor, from McDaniel College in Westminster, Maryland.

About Concordance

Concordance is a CARF-accredited nonprofit that offers holistic, and evidence-informed services to individuals returning to their community from prison. Founded in 2015 by Danny Ludeman, former CEO of Wells Fargo Advisors, Concordance has lowered the rate of reincarceration by 56 percent among its participants who have released from prison in the last three years. The nonprofit works with individuals in three primary areas: behavioral health and wellness; education and employment; and community and life skills. Concordance is committed to healing individuals, reuniting families, transforming communities, achieving racial equity, and advancing the field of re-entry services. Headquartered in St. Louis, Concordance is working toward national expansion, with plans to bring its re-entry model to 11 additional cities nationwide over the next five years. For more information, visit https://concordance.org. Resources for news media including fact sheets, photos, and videos are available at https://concordance.org/media-kit.

CONCORDANCE MEDIA CONTACTS

Jill Lewin - 314-396-6024
[email protected]

Sivan Fernandez - 314-396-6045
[email protected]




Press Release Service by Newswire.com

Original Source: Concordance Names Clinton 'Lee' Holmes as Chief Administrative Officer

Wealth Management CEO Charges That Average Investor Returns Are Well Under Long-Term Market Performance

0
Wealth Management CEO Charges That Average Investor Returns Are Well Under Long-Term Market Performance
MANASSAS, Va. - September 7, 2022 - (Newswire.com)

A much sought-after financial advisor, CEO of Rosenthal Wealth Management Group (RWMG) Larry Rosenthal, charges that the average investor underperforms the market* over the long term due to three key financial oversights. 

According to Rosenthal, investors often fail to:

1. Understand risk protection

2. Stay invested during market volatility

3. Buy when markets are low

"These are just the biggest reasons why returns on investments (ROI) aren't higher. There are several more common pitfalls that must be avoided, such as failure to set proper tax allocation, failure to carry out proper estate planning and not compensating for individual risk management tolerances, that also play a role in ROI.  Further, because of current inflation pressures, it is now even more important that investments be carefully managed to maximize yield. Investors need to make sure that they are acting on the most current and accurate market analysis to guide their financial decisions," Rosenthal said.

Toward that end, Rosenthal provides interested persons complimentary access to webinars that deliver updated news on the current economic and stock market environment as it relates to personal financial planning. The next RWMG webinar is scheduled for Sept. 14, 2022. Interested persons can get access to this seminar by visiting RosenthalWealthManagement.com

"RWMG has always acted as a financial educational hub and a touchstone for reliable financial/estate planning. RWMG can help investors identify blind spots in dealing with estate planning and show interested persons how to cut through the fluff and learn about the economy and how it affects their investment strategies and recession possibilities. They need to more fully understand why the average investor gets returns well under market performance," Rosenthal says.

Rosenthal has appeared regularly on Fox Business News and has been quoted in The Wall Street Journal, CNNMoney, U.S. News and World Report, CNBC's The Nightly Business Report, The Washington Post, USA Today, Money, Bloomberg, The Chicago Tribune, The Fiscal Times, Kiplinger's Retirement Report, Consumer Report's Money Advisor, The Washington Times, Financial Planning, Financial Advisor and others.

Rosenthal has been providing financial counseling for about three decades. He is based out of the D.C. Metro area but serves clients nationwide.  

Rosenthal is also the national radio show host of "Making Money Sense." The show has aired every Saturday morning on DC's WAVA from 9:00-10:00 a.m. for nearly two decades. The national show is simulcast via satellite on SiriusXM channel 131.

Investment Adviser Representative(s) offering Securities and advisory services through Cetera Advisor Networks LLC, member FINRA/SIPC, a Broker/ Dealer & Registered investment Adviser. Cetera is under separate ownership from any other named entity. RWMG is headquartered at 9265 Corporate Circle, Manassas, Va. 20110.

Rosenthal Wealth Management Group is not a subsidiary of nor controlled by Cetera.

*JPMorgan Guide to the market. All investing involves risk, including the possible loss of principal. There is no assurance that any investment strategy will be successful. For a comprehensive review or your personal situation, always consult with a tax or legal advisor. Neither Cetera Advisor Networks LLC nor any of its representatives may give legal or tax advice.

Contact: Bob Johns 7039556622, [email protected]




Press Release Service by Newswire.com

Original Source: Wealth Management CEO Charges That Average Investor Returns Are Well Under Long-Term Market Performance

Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care

0
Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care
ADHD Online alleviates overburdened system's long wait times for patients to receive ADHD assessments, treatments, and care

GRAND RAPIDS, Mich. - September 7, 2022 - (Newswire.com)

An ongoing strike by mental health workers, coupled with state laws that mandate urgent responses to mental health issues, highlight the need for expanded resources for mental health care such as the assessment, diagnosis and treatment services provided by ADHD Online.

Recent events in California highlight a looming national problem. A new state law, passed in 2021, mandates that mental health providers respond quickly to requests for mental health care - including offering appointments within 10 business days. Psychologists, therapists and other mental health professionals say they are stretched too thinly, prompting the strike.

Those resource constraints force routine procedures like ADHD assessments to be treated as low priority, creating months-long wait times for assessments. Strikes by mental health push out ADHD assessment appointments even further, past 12 months in most cases, according to ADHD Online. And that places tremendous stress on individuals and families.

"Because ADHD assessments are not considered urgent, a family member may be waiting far too long to get answers and start living a better life," said Zachariah Booker, CEO and co-founder of ADHD Online. "If you've had that experience, you know that you can't get answers quickly enough."

ADHD Online, founded in 2018, alleviates the burden on traditional mental health services through its system of HIPAA-secured, online ADHD assessments that connect people with licensed, doctoral-level psychologists who can perform ADHD assessments within three to five days.

ADHD Online's certified assessments and any resulting diagnoses can be taken to patients' own primary care providers for treatment, or the patient can use ADHD Online's network of providers for ongoing treatment. In select states, ADHD Online also offers streamlined teletherapy appointments with master-level clinicians over HIPAA-compliant Zoom accounts.

"We know that the mental health care system is overburdened and that people need better ways to get the care they need," Booker said. "Our mission is to ensure that everyone should have access to quality ADHD assessments regardless of who and where they are, and we have built a team of licensed professionals who are passionate about providing that care."

ADHD Online is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. After diagnosis, ADHD Online providers and patients develop an ADHD treatment plan which may include medication and therapy, but the company does not advocate for treating all patients with medication and has no relationships with pharmaceutical companies.

For any patients beginning medication, ADHD Online requires an initial 30-day follow-up visit and repeated 90-day follow-ups if the patient is stable on their medications. Patients also provide their vital signs to ADHD Online throughout their care. 

Please visit https://adhdonline.com for more information.

About ADHD Online

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states.

Media Contact

Dan Johnson
[email protected]




Press Release Service by Newswire.com

Original Source: Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH

0
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH
The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) enter a strategic partnership to use artificial intelligence (AI) powered tool for the diagnosis and staging of NASH (non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).


FibroNest's AI scores Fibrosis Severity in Liver Biopsies

Liver Biopsies in three different stages of fibrosis severity are automatically scored by Fibronest with reproducibility and detection thresholds that exceed current methods

PARIS - September 7, 2022 - (Newswire.com)

The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) announced today that they have entered a strategic partnership that will support the development and validation of a virtual liver biopsy (non-invasive) and artificial intelligence (AI)-powered tool for the diagnosis and staging of NASH (Non-Alcoholic Steatohepatitis) in patients with type 2 diabetes (T2D).

The clinical study involves 600 type 2 diabetic patients who are receiving a liver biopsy as part of standard care. The data collected (imaging, deep clinico-biological phenotyping, different omic approaches, extracellular vesicles and immune blood cell profiling) will be analyzed with the Swiss Institute of Bioinformatics (SIB) and Bichat biostatistical teams through comprehensive and deep bioinformatics and biostatistics. 

Through its cloud-based, Digital Pathology platform FibroNest, PharmaNest will generate single-fiber and single-nuclei high-content quantitative histological datasets from each digital biopsy image to generate continuous scores that quantify the phenotypes of fibrosis and stage the severity of fibrosis and disease activity of NASH. This dataset will enrich the data collected and enable the consortium to discover novel histological phenotypes of NASH in T2D  patients.

"The quantitative FibroNest method resolves the limitation of the current categorical and semi-quantitative methods and paradigms used of the histological assessment of liver biopsies," says Prof. Valerie Paradis, Chair of the Pathology Department at Beaujon Hospital and leader of the INSERM team.

"PharmaNest is excited to enable the QUID NASH consortium to enter the research field of Pathomic-Fusion and provide a robust and automated method for the quantification of the fibrosis," says Mathieu Petitjean, Ph.D., CEO of PharmaNest, Inc. 

"The addition of FibroNest's Digital Pathology and Artificial intelligence capabilities to the QUID-NASH consortium will enhance performance of our upcoming virtual biopsy tests and generate significant upside for the investigation and understanding of NASH in T2D patients," says Pr. Dominique Valla, Principal Investigator and founding director of the French Reference Center for Vascular Diseases of the Liver

About QUID-NASH

The QUID-NASH research program is a clinical research consortium that includes Assistance Publique-Hôpitaux de Paris, Universities Paris-Descartes and Paris-Diderot, Commissariat à l'Energie Atomique (CEA), Laboratoires Servier and BioPredictive which operate under the leadership of the National Institute of Health and Medical Research (INSERM) of France. Clinical sites and teams include diabetology in Lariboisière and Cochin hospitals, Hepatology in Beaujon and Cochin, Imaging in Necker Beaujon and Physics for Medecine Paris. 

About PharmaNest

PharmaNest is a Digital Pathology and Artificial Intelligence company focused on the development and validation of novel histological standards for the quantification of Inflammation and fibrosis. Its multivendor platform, FibroNest, is delivered worldwide via the cloud and used in multiple pre-clinical and clinical studies across several fibrotic conditions.

For more information about FibroNest and PharmaNest, visit www.pharmanest.com and www.fibronest.com

Media Contact

Mathieu M. Petitjean, Ph.D.

CEO, PharmaNest

E: [email protected]




Press Release Service by Newswire.com

Original Source: The QUID-NASH Research Consortium (Paris, France) and PharmaNest, Inc. (Princeton, USA) Enter a Strategic Partnership for the Study of NASH